|
|
Volumn 13, Issue 2, 2008, Pages 126-138
|
|
Battling the hematological malignancies: The 200 years' war
|
|
Author keywords
Cancer; Cancer therapy; Leukemia; Lymphoma; Myeloma
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANTIMETABOLITE;
ANTINEOPLASTIC ANTIBIOTIC;
ARSENIC TRIOXIDE;
AZACITIDINE;
BISPHOSPHONIC ACID DERIVATIVE;
BLEOMYCIN;
BLEOMYCIN SULFATE;
BORTEZOMIB;
BUSULFAN;
CARBOPLATIN;
CARMUSTINE;
CHLORAMBUCIL;
CHLORMETHINE;
CISPLATIN;
CLADRIBINE;
CLOFARABINE;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DACARBAZINE;
DACOGE;
DASATINIB;
DAUNORUBICIN;
DEXAMETHASONE;
DOXORUBICIN;
DROXIA;
ETOPOFOS;
ETOPOSIDE;
FLUDARABINE PHOSPHATE;
GEMTUZUMAB OZOGAMICIN;
GLUCOCORTICOID;
HISTONE DEACETYLASE INHIBITOR;
HYDROXYUREA;
IBRITUMOMAB TIUXETAN;
IDARUBICIN;
IFOSFAMIDE;
IMATINIB;
LENALIDOMIDE;
LOMUSTINE;
MELPHALAN;
MERCAPTOPURINE;
METHOTREXATE;
METHYLPREDNISOLONE;
MITOXANTRONE;
MONOCLONAL ANTIBODY;
NILOTINIB;
ONCOPROTEIN;
PACLITAXEL;
PAMIDRONIC ACID;
PREDNISONE;
PROCARBAZINE;
PROTEASOME INHIBITOR;
PROTEIN TYROSINE KINASE INHIBITOR;
RECOMBINANT ALPHA2A INTERFERON;
RECOMBINANT ALPHA2B INTERFERON;
RETINOIC ACID;
RITUXIMAB;
TABLOID;
TENIPOSIDE;
THALIDOMIDE;
THALMID;
TIOGUANINE;
TOPOTECAN;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VINBLASTINE SULFATE;
VINCRISTINE SULFATE;
VORINOSTAT;
ZOLEDRONIC ACID;
ACUTE GRANULOCYTIC LEUKEMIA;
ACUTE LEUKEMIA;
ACUTE LYMPHOCYTIC LEUKEMIA;
AGING;
CANCER GROWTH;
CANCER RADIOTHERAPY;
CANCER REGRESSION;
CANCER RESEARCH;
CANCER RISK;
CANCER STEM CELL;
CANCER SURVIVAL;
CANCER THERAPY;
CELL DEATH;
CELL HETEROGENEITY;
CELL SURVIVAL;
CHRONIC LYMPHATIC LEUKEMIA;
CHRONIC MYELOID LEUKEMIA;
DRUG COST;
DRUG INDUSTRY;
DRUG MECHANISM;
DRUG TARGETING;
GENETIC PREDISPOSITION;
GENETIC VARIABILITY;
GOVERNMENT;
GROWTH INHIBITION;
HEMATOLOGIC MALIGNANCY;
HODGKIN DISEASE;
HUMAN;
INCIDENCE;
LIFESPAN;
LONG TERM CARE;
LYMPHOMA;
MICROORGANISM;
MITOSIS INHIBITION;
MYELOMA;
NONHODGKIN LYMPHOMA;
ONCOGENE;
PALLIATIVE THERAPY;
PATIENT CARE;
PHENOTYPE;
PHOTOTHERAPY;
PRIORITY JOURNAL;
REVIEW;
TREATMENT FAILURE;
TREATMENT OUTCOME;
UNITED STATES;
UNSPECIFIED SIDE EFFECT;
WAR;
AGE FACTORS;
ANTINEOPLASTIC AGENTS;
GENETIC PREDISPOSITION TO DISEASE;
HISTORY, 19TH CENTURY;
HISTORY, 20TH CENTURY;
HISTORY, 21ST CENTURY;
HUMANS;
LEUKEMIA;
LYMPHOMA;
MULTIPLE MYELOMA;
RISK FACTORS;
TIME FACTORS;
TREATMENT OUTCOME;
|
|
EID: 40349113288
PISSN: 10837159
EISSN: 1549490X
Source Type: Journal
DOI: 10.1634/theoncologist.2007-0228 Document Type: Review |
|
Times cited : (70)
|
|
References (39)
|
